| # | Drug | Count |
|---|---|---|
| 0 | VENETOCLAX | 118 |
| 1 | BLINATUMOMAB | 102 |
| 2 | DEXAMETHASONE | 99 |
| 3 | DEXAMETHASONE 1.5 MG | 99 |
| 4 | CYCLOPHOSPHAMIDE | 78 |
| 5 | CYCLOPHOSPHAMIDE FOR INJECTION | 78 |
| 6 | CYCLOPHOSPHAMIDE INJECTION, SOLUTION | 78 |
| 7 | METHOTREXATE SODIUM | 69 |
| 8 | METHOTREXATE | 65 |
| 9 | AZACITIDINE | 59 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | BETIBEGLOGENE AUTOTEMCEL | 1 | 0.0179 |
| 1 | BLINATUMOMAB | 102 | 0.0095 |
| 2 | RYDAPT | 9 | 0.0046 |
| 3 | NELARABINE | 4 | 0.0041 |
| 4 | MITOXANTRONE HYDROCHLORIDE | 22 | 0.0035 |
| 5 | INOTUZUMAB OZOGAMICIN | 10 | 0.0033 |
| 6 | ASPARAGINASE ERWINIA CHRYSANTHEMI (RECOMBINANT)-RYWN | 1 | 0.0029 |
| 7 | DASATINIB | 25 | 0.0027 |
| 8 | LONCASTUXIMAB TESIRINE | 1 | 0.0024 |
| 9 | TREOSULFAN | 6 | 0.0022 |
| # | Drug class | Count |
|---|---|---|
| 0 | Nucleoside Metabolic Inhibitor [EPC] | 123 |
| 1 | Corticosteroid [EPC] | 119 |
| 2 | BCL-2 Inhibitor [EPC] | 118 |
| 3 | Alkylating Drug [EPC] | 92 |
| 4 | Folate Analog Metabolic Inhibitor [EPC] | 65 |
| 5 | Kinase Inhibitor [EPC] | 42 |
| 6 | Topoisomerase Inhibitor [EPC] | 40 |
| 7 | Proteasome Inhibitor [EPC] | 39 |
| 8 | CD20-directed Cytolytic Antibody [EPC] | 31 |
| 9 | Thalidomide Analog [EPC] | 28 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | CD38-directed Cytolytic Antibody [EPC] | 20 | 0.0034 |
| 1 | CD22-directed Immunoconjugate [EPC] | 10 | 0.0033 |
| 2 | BCL-2 Inhibitor [EPC] | 118 | 0.0019 |
| 3 | Actinomycin [EPC] | 2 | 0.0009 |
| 4 | Hematopoietic Stem Cell Mobilizer [EPC] | 1 | 0.0007 |
| 5 | Ergot Derivative [EPC] | 3 | 0.0006 |
| 6 | Endoglycosidase [EPC] | 1 | 0.0005 |
| 7 | Topoisomerase Inhibitor [EPC] | 40 | 0.0005 |
| 8 | Asparagine-specific Enzyme [EPC] | 7 | 0.0005 |
| 9 | Nucleoside Metabolic Inhibitor [EPC] | 123 | 0.0004 |